Form D — Sonavex, Inc.
0001645892-26-000003 · filed Jul 28, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $15,000,000
- Reported amount sold
- $3,102,995
- Minimum investment
- $0
- Investors
- 5
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Sonavex, Inc.
- CIK
- 1645892
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 2835 O'DONNELL STREET
BALTIMORE, MD 21224 - Phone
- 443.862.2024
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
David Narrow · Executive OfficerBaltimore, MD Find on LinkedIn ↗
-
Devin O'Brien-Coon · DirectorBaltimore, MD Find on LinkedIn ↗
-
Alex Yevzlin · Executive OfficerBaltimore, MD Find on LinkedIn ↗
-
William Niland · DirectorBaltimore, MD Find on LinkedIn ↗
-
Robert Hallenbeck · DirectorBaltimore, MD Find on LinkedIn ↗
-
Evan Pritchard · DirectorBaltimore, MD Find on LinkedIn ↗
-
Michael J. Hennessy, Jr. · DirectorBaltimore, MD Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗